Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus.

Abali S., Turan S., Atay Z., GÜRAN T., Haliloglu B., BEREKET A.

Pediatric diabetes, cilt.16, sa.5, ss.361-6, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 5
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/pedi.12167
  • Dergi Adı: Pediatric diabetes
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.361-6
  • Anahtar Kelimeler: children, detemir, glargine, HbA1c, T1D, TREAT-TO-TARGET, PHARMACOKINETIC PROPERTIES, ANALOGS DETEMIR, STEADY-STATE, DOUBLE-BLIND, NPH INSULIN, LONG, ADOLESCENTS, VARIABILITY, PROFILE
  • Marmara Üniversitesi Adresli: Evet

Özet

ObjectiveWe aimed to compare hemoglobin A1c (HbA1c), total and basal insulin doses, basal insulin injection frequencies, and body mass index (BMI) in children with type 1 diabetes mellitus (T1DM) who are receiving detemir and glargine as basal insulin in a basal-bolus therapy.